SLC6A3 and Parkinson disease: Radiotracer-based PET and SPECT imaging provide a sensitive and objective means of detecting dopamine terminal dysfunction in PD and DLB, and the use of DAT SPECT or PET can support a diagnosis of these conditions in which doubt exists and rationalize the use of dopamine replacement therapy.